173 related articles for article (PubMed ID: 27565576)
1. Functional exhaustion of CD4
Ozkazanc D; Yoyen-Ermis D; Tavukcuoglu E; Buyukasik Y; Esendagli G
Immunology; 2016 Dec; 149(4):460-471. PubMed ID: 27565576
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts.
Poh SL; Linn YC
Cancer Immunol Immunother; 2016 May; 65(5):525-36. PubMed ID: 26961084
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
4. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Huang YH; Zhu C; Kondo Y; Anderson AC; Gandhi A; Russell A; Dougan SK; Petersen BS; Melum E; Pertel T; Clayton KL; Raab M; Chen Q; Beauchemin N; Yazaki PJ; Pyzik M; Ostrowski MA; Glickman JN; Rudd CE; Ploegh HL; Franke A; Petsko GA; Kuchroo VK; Blumberg RS
Nature; 2015 Jan; 517(7534):386-90. PubMed ID: 25363763
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
6. Expression of immune checkpoints in T cells of esophageal cancer patients.
Xie J; Wang J; Cheng Sh; Zheng L; Ji F; Yang L; Zhang Y; Ji H
Oncotarget; 2016 Sep; 7(39):63669-63678. PubMed ID: 27577071
[TBL] [Abstract][Full Text] [Related]
7. Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.
Du Four S; Maenhout SK; Benteyn D; De Keersmaecker B; Duerinck J; Thielemans K; Neyns B; Aerts JL
Cancer Immunol Immunother; 2016 Jun; 65(6):727-40. PubMed ID: 27098427
[TBL] [Abstract][Full Text] [Related]
8. Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia.
Pan S; Cai Q; Wei Y; Tang H; Zhang Y; Zhou W; Deng T; Mo W; Wang S; Wang C; Chen C
Immunobiology; 2024 May; 229(3):152804. PubMed ID: 38615511
[TBL] [Abstract][Full Text] [Related]
9. Differential expression pattern of co-inhibitory molecules on CD4
Abel A; Steeg C; Aminkiah F; Addai-Mensah O; Addo M; Gagliani N; Casar C; Yar DD; Owusu-Dabo E; Jacobs T; Mackroth MS
Sci Rep; 2018 Mar; 8(1):4789. PubMed ID: 29555909
[TBL] [Abstract][Full Text] [Related]
10. Lactate acid promotes PD-1
Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
[TBL] [Abstract][Full Text] [Related]
11. TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8
Lake CM; Voss K; Bauman BM; Pohida K; Jiang T; Dveksler G; Snow AL
Cell Death Dis; 2021 Apr; 12(4):400. PubMed ID: 33854046
[TBL] [Abstract][Full Text] [Related]
12. Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
Houtenbos I; Westers TM; Stam AG; de Gruijl TD; Scheper RJ; Ossenkoppele GJ; van de Loosdrecht AA
Cancer Immunol Immunother; 2003 Jul; 52(7):455-62. PubMed ID: 12690520
[TBL] [Abstract][Full Text] [Related]
13. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.
McKinney EF; Lee JC; Jayne DR; Lyons PA; Smith KG
Nature; 2015 Jul; 523(7562):612-6. PubMed ID: 26123020
[TBL] [Abstract][Full Text] [Related]
14. Prognostic effect of CTLA4/LAG3 Expression by T-Cells Subsets on Acute Myeloid Leukemia Patients.
El Dosoky W; Aref S; El Menshawy N; Ramez A; Abou Zaid T; Aref M; Atia D
Asian Pac J Cancer Prev; 2024 May; 25(5):1777-1785. PubMed ID: 38809650
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen?
Lim SH; Worman CP; Goldstone AH
Cancer Immunol Immunother; 1991; 33(6):417-20. PubMed ID: 1878895
[TBL] [Abstract][Full Text] [Related]
16. Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
Kawashima A; Kanazawa T; Goto K; Matsumoto M; Morimoto-Okazawa A; Iwahori K; Ujike T; Nagahara A; Fujita K; Uemura M; Nonomura N; Wada H
Cancer Immunol Immunother; 2018 Jan; 67(1):113-125. PubMed ID: 28975380
[TBL] [Abstract][Full Text] [Related]
17. The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Shibamiya A; Miyamoto-Nagai Y; Koide S; Oshima M; Rizq O; Aoyama K; Nakajima-Takagi Y; Kato R; Kayamori K; Isshiki Y; Oshima-Hasegawa N; Muto T; Tsukamoto S; Takeda Y; Koyama-Nasu R; Chiba T; Honda H; Yokote K; Iwama A; Sakaida E; Mimura N
Cancer Immunol Immunother; 2023 Aug; 72(8):2635-2648. PubMed ID: 37069353
[TBL] [Abstract][Full Text] [Related]
18. Roles, function and relevance of LAG3 in HIV infection.
Graydon CG; Balasko AL; Fowke KR
PLoS Pathog; 2019 Jan; 15(1):e1007429. PubMed ID: 30653605
[TBL] [Abstract][Full Text] [Related]
19. TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.
Cianciotti BC; Magnani ZI; Ugolini A; Camisa B; Merelli I; Vavassori V; Potenza A; Imparato A; Manfredi F; Abbati D; Perani L; Spinelli A; Shifrut E; Ciceri F; Vago L; Di Micco R; Naldini L; Genovese P; Ruggiero E; Bonini C
Front Immunol; 2024; 15():1315283. PubMed ID: 38510235
[TBL] [Abstract][Full Text] [Related]
20. PD-1 and LAG-3 positive T cells are related with the prognosis of patients with chronic kidney disease.
Jiang H; Wu J; Zhang J
Exp Cell Res; 2024 May; 438(1):114027. PubMed ID: 38574959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
